These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 38245249)

  • 21. Phenotypic manifestation of α-synuclein strains derived from Parkinson's disease and multiple system atrophy in human dopaminergic neurons.
    Tanudjojo B; Shaikh SS; Fenyi A; Bousset L; Agarwal D; Marsh J; Zois C; Heman-Ackah S; Fischer R; Sims D; Melki R; Tofaris GK
    Nat Commun; 2021 Jun; 12(1):3817. PubMed ID: 34155194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CSF-derived extracellular vesicles from patients with Parkinson's disease induce symptoms and pathology.
    Herman S; Djaldetti R; Mollenhauer B; Offen D
    Brain; 2023 Jan; 146(1):209-224. PubMed ID: 35881523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Disease-Modifying Therapy for Parkinson's Disease].
    Shimura H; Hattori N
    Brain Nerve; 2017 Feb; 69(2):159-165. PubMed ID: 28202824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson's disease brain.
    Roberts RF; Wade-Martins R; Alegre-Abarrategui J
    Brain; 2015 Jun; 138(Pt 6):1642-57. PubMed ID: 25732184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysbiosis of the gut microbiota and its effect on α-synuclein and prion protein misfolding: consequences for neurodegeneration.
    Mahbub NU; Islam MM; Hong ST; Chung HJ
    Front Cell Infect Microbiol; 2024; 14():1348279. PubMed ID: 38435303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
    Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
    Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microglial exosomes facilitate α-synuclein transmission in Parkinson's disease.
    Guo M; Wang J; Zhao Y; Feng Y; Han S; Dong Q; Cui M; Tieu K
    Brain; 2020 May; 143(5):1476-1497. PubMed ID: 32355963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parkinson's disease risk genes act in glia to control neuronal α-synuclein toxicity.
    Olsen AL; Feany MB
    Neurobiol Dis; 2021 Nov; 159():105482. PubMed ID: 34390834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathological and clinical aspects of alpha/beta synuclein in Parkinson's disease and related disorders.
    Tolmasov M; Djaldetti R; Lev N; Gilgun-Sherki Y
    Expert Rev Neurother; 2016 May; 16(5):505-13. PubMed ID: 26959397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From the Gut to the Brain: The Role of Enteric Glial Cells and Their Involvement in the Pathogenesis of Parkinson's Disease.
    Montalbán-Rodríguez A; Abalo R; López-Gómez L
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys.
    Alarcón-Arís D; Pavia-Collado R; Miquel-Rio L; Coppola-Segovia V; Ferrés-Coy A; Ruiz-Bronchal E; Galofré M; Paz V; Campa L; Revilla R; Montefeltro A; Kordower JH; Vila M; Artigas F; Bortolozzi A
    EBioMedicine; 2020 Sep; 59():102944. PubMed ID: 32810825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.
    Coskuner-Weber O; Uversky VN
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropathology of α-synuclein propagation and braak hypothesis.
    McCann H; Cartwright H; Halliday GM
    Mov Disord; 2016 Feb; 31(2):152-60. PubMed ID: 26340605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson's disease-like pathology in neurons and glia.
    Henrich MT; Geibl FF; Lee B; Chiu WH; Koprich JB; Brotchie JM; Timmermann L; Decher N; Matschke LA; Oertel WH
    Acta Neuropathol Commun; 2018 May; 6(1):39. PubMed ID: 29747690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prion-like spreading of α-synuclein: From in vitro to in vivo models of Parkinson's disease.
    Vargas JY; Grudina C; Zurzolo C
    Ageing Res Rev; 2019 Mar; 50():89-101. PubMed ID: 30690184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. α-Synuclein nonhuman primate models of Parkinson's disease.
    Marmion DJ; Kordower JH
    J Neural Transm (Vienna); 2018 Mar; 125(3):385-400. PubMed ID: 28434076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spreading of alpha-synuclein - relevant or epiphenomenon?
    Killinger BA; Kordower JH
    J Neurochem; 2019 Sep; 150(5):605-611. PubMed ID: 31152606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ABBV-0805, a novel antibody selective for soluble aggregated α-synuclein, prolongs lifespan and prevents buildup of α-synuclein pathology in mouse models of Parkinson's disease.
    Nordström E; Eriksson F; Sigvardson J; Johannesson M; Kasrayan A; Jones-Kostalla M; Appelkvist P; Söderberg L; Nygren P; Blom M; Rachalski A; Nordenankar K; Zachrisson O; Amandius E; Osswald G; Moge M; Ingelsson M; Bergström J; Lannfelt L; Möller C; Giorgetti M; Fälting J
    Neurobiol Dis; 2021 Dec; 161():105543. PubMed ID: 34737044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut-to-Brain α-Synuclein Transmission in Parkinson's Disease: Evidence for Prion-like Mechanisms.
    Chen M; Mor DE
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein.
    Elgueta D; Chovar O; Ugalde V; Sánchez-Guajardo V; Catenaccio A; Court F; Pacheco R
    J Vis Exp; 2022 Jul; (185):. PubMed ID: 35969046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.